Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Accelerated Phase × Bortezomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 89 Neoplasms, Plasma Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 6 Immunoglobulin Light-chain Amyloidosis 6 Recurrence 5 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Paraproteinemias 3 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Renal Insufficiency 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Amyloidosis 2 beta-Thalassemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Sarcoma, Myeloid 1 Plasmacytoma 1 Peripheral Nervous System Diseases 1 Neoplasm, Residual 1

Interventions

Cyclophosphamide 8 fludarabine phosphate 5 Methotrexate 5 ponatinib 4 Whole-Body Irradiation 4 merphos 3 Tacrolimus 3 Rituximab 3 Peripheral Blood Stem Cell Transplantation 3 Mycophenolic Acid 3 CT-P10 3 Busulfan 3 letermovir 2 Vincristine 2 Melphalan 2 Cytarabine 2 Cyclosporine 2 venetoclax 1 prednylidene 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 bosutinib 1 blinatumomab 1 auricularum 1 Vorinostat 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡